Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
The Journal of Biological Chemistry|May 8, 2007
Improved stability of the Jun-Fos Activator Protein-1 coiled coil motif: A stopped-flow circular dichroism kinetic analysisJody M Mason, Urs B Hagemann, Katja M ArndtBiochemistry|September 12, 2009
Role of hydrophobic and electrostatic interactions in coiled coil stability and specificityJody M Mason, Urs B Hagemann, Katja M ArndtJournal of Molecular Biology|July 1, 2008
Selectional and mutational scope of peptides sequestering the Jun-Fos coiled-coil domainUrs B Hagemann, Jody M Mason, Kristian M Müller, et al.Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Selection of peptides interfering with protein-protein interactionAnnette Gaida, Urs B Hagemann, Dinah Mattay, et al.Cancer Research|August 8, 2019
Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle IrradiationBrian D Yard, Priyanka Gopal, Kristina Bannik, et al.Nuclear Medicine Communications|April 9, 2014
Automated functional characterization of radiolabeled antibodies: a time-resolved approachEllen Wang, Hanna Björkelund, Dessislava Mihaylova, et al.Plos One|August 1, 2014
Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxisUrs B Hagemann, Lavinia Gunnarsson, Solène Géraudie, et al.Oncotarget|September 17, 2017
Targeted alpha therapy using a novel CD70 targeted thorium-227 conjugate in in vitro and in vivo models of renal cell carcinomaUrs B Hagemann, Dessislava Mihaylova, Steinar R Uran, et al.Biomacromolecules|July 30, 2014
Analysis of selected and designed chimeric D- and L-α-helix assembliesTim Kükenshöner, Urs B Hagemann, Daniel Wohlwend, et al.Oncotarget|October 23, 2018
Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer modelsMaria Quanz, Urs B Hagemann, Sabine Zitzmann-Kolbe, et al.Pageof 3